Pith. sign in

REVIEW 3 major objections 6 minor 63 references

Development and in silico imaging trial evaluation of a deep-learning-based transmission-less attenuation compensation method for DaT SPECT

T0 review · 3 major / 6 minor · reviewed 2026-08-06 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read DaT SPECT attenuation correction can be done without a CT scan by segmenting scatter-window reconstructions with a U-net, matching CT-based correction in an in silico trial.

desk verdict A carefully designed in silico imaging trial for a transmission-less DaT SPECT AC method; the pooled-ICC analysis needs a closer look, but the core result is credible. read the letter →

arxiv 2506.20781 v1 pith:KZ23ARYH submitted 2025-06-25 physics.med-ph

Zitong Yu , Md Ashequr Rahman , Zekun Li , Chunwei Ying , Hongyu An , Tammie L.S. Benzinger , Richard Laforest , Jingqin Luo
show 2 more authors
Scott A. Norris Abhinav K. Jha
This is my paper · ORCID
classification physics.med-ph
keywords DaTSPECTtransmission-lessattenuationcompensationdeeplearninginsilicoimagingtrialscatter-energywindowregionaluptakequantificationspecificbindingratiomapsegmentation
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper proposes and evaluates DaT-CTLESS, a deep-learning method that performs attenuation compensation for dopamine-transporter (DaT) brain SPECT without any transmission or CT scan. Its central claim is that regional DaT uptake measured after DaT-CTLESS correction tracks CT-based attenuation correction (CTAC) far more closely than the standard CT-free fallback, a uniform attenuation map (UAC). In the ISIT-DaT in silico trial, the intraclass correlation with CTAC was 0.96 (95% CI [0.94, 0.97]) for DaT-CTLESS versus 0.44 for UAC. The method also beat UAC at distinguishing normal from reduced putamen binding, matched CTAC in test-retest repeatability, generalized across two simulated scanners, and held its accuracy with as few as 50 training patients. These results motivate moving the method into clinical evaluation.

What carries the argument

The load-bearing mechanism is the scatter-energy-window reconstruction as the physical source of attenuation information, combined with a U-net (a convolutional encoder-decoder network) that converts that reconstruction into a small set of attenuation regions rather than per-voxel coefficients. Because Compton scatter probability at a location tracks the attenuation coefficient there, scatter-window projections carry attenuation information even from structures with no tracer uptake, such as the head gear that UAC cannot see. The segmentation step reframes a high-dimensional, ill-posed voxel-estimation problem as a low-dimensional region-labeling problem, which is why the method needs little training data and outperforms voxel-wise deep-learning estimators.

What would settle it

Scan real patients on a SPECT/CT system, derive DaT-CTLESS attenuation maps from SPECT data alone, and compare regional uptake with same-day CTAC; if the ICC falls to the level of UAC (around 0.44) or head-gear attenuation is missed in patients who moved during acquisition, the central claim would be refuted.

Watch

Extended reading notes

Core claim

On the paper's own terms, the discovery is that the attenuation map needed for quantitative DaT SPECT can be recovered from the emission data itself by treating attenuation-map estimation as a segmentation problem. DaT-CTLESS takes photopeak- and scatter-energy-window reconstructions as input to a U-net that labels attenuation regions, including white/gray matter, skull, scalp, and head gear, and then assigns each region a fixed attenuation coefficient. In the ISIT-DaT virtual trial this pipeline produced regional uptake estimates with an ICC of 0.96 against CTAC, significantly higher than the 0.44 ICC between UAC and CTAC, at similar fidelity to ground truth and similar test-retest repeatability to CTAC. It also outperformed direct and per-voxel indirect deep-learning AC methods across training set sizes, which the paper attributes to the dimensionality reduction of segmentation.

Load-bearing premise

The trial assumes that the Monte Carlo simulations and the virtual patient anatomy faithfully reproduce clinical DaT SPECT, especially the scatter-window projections; if that simulated physics differs from real scans, the learned segmentation may not transfer.

Editorial extensions

If this is right

  • SPECT systems without a CT component could obtain attenuation compensation approaching CT-based accuracy, removing a barrier for community, mobile, and solid-state-detector scanners.
  • Eliminating the CT scan removes SPECT-CT misalignment as a source of quantification error, a practical concern for Parkinson patients who move during scanning.
  • Large existing SPECT databases that lack transmission scans could become usable for quantitative DaT uptake analysis.
  • Because the method is formulated as segmentation, it may be retrainable for other tracers or brain SPECT protocols with modest training data.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The central comparison is only as strong as the simulation; a real-world clinical study is the natural next test, and the paper itself lists this as future work.
  • If real scatter data include motion or head-gear variations not captured in the Monte Carlo model, scanner- or protocol-specific retraining may be needed before deployment.
  • The same scatter-window-plus-segmentation idea could be tested for attenuation compensation in other SPECT tracers and possibly outside the brain, since the scatter-attenuation correlation is not specific to DaT imaging.
  • Because training labels come from CT-derived segmentations, the method's ceiling is the accuracy of those segmentations; clinical transfer would depend on CT-derived regions matching real anatomy.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 6 minor

Summary. The manuscript proposes DaT-CTLESS, a deep-learning-based transmission-less attenuation compensation method for dopamine transporter (DaT) SPECT. The method reconstructs scatter-window and photopeak-window projections, uses a U-net with attention gates to segment an initial scatter-window reconstruction into attenuation regions (white/gray matter, skull, scalp, head gear), assigns predefined literature-based attenuation coefficients to those regions, and uses the resulting attenuation map for OSEM reconstruction. The method is evaluated in an in silico imaging trial (ISIT-DaT) with 150 virtual patients for training and 47 for testing, generated from real MR/CT anatomy and clinical SBR distributions, simulated with SIMIND on GE and Siemens scanners. The primary endpoint is the ICC between regional DaT uptake estimates from DaT-CTLESS and CTAC versus the ICC between UAC and CTAC; secondary endpoints include AUC for normal versus reduced putamen SBR, test-retest repeatability, cross-scanner generalizability, fidelity-based FoMs, sensitivity to intra-regional heterogeneity, and comparison with two other DL-based AC methods. The authors report ICC 0.96 (95% CI 0.94–0.97) for DaT-CTLESS versus CTAC and 0.44 for UAC, and conclude that DaT-CTLESS is a reliable transmission-less AC method.

Significance. If the central claim is fully supported, DaT-CTLESS addresses a real clinical need: many DaT SPECT systems lack CT, and CT-based AC adds dose, cost, and misregistration risk. The study is significant for its adoption of the in silico imaging trial paradigm with a pre-specified primary endpoint, a power analysis, bootstrap confidence intervals, and multi-vendor scanner simulation. The authors credit the RELAINCE guidelines and evaluate on clinically relevant tasks. The method's use of scatter-window information is physically motivated, and the segmentation-based approach with literature-assigned attenuation coefficients avoids circularity from fitting attenuation values to the outcome. The secondary analyses, including test-retest repeatability and training-set-size sensitivity, are thoughtful. However, the primary endpoint analysis has a statistical weakness that must be addressed before the headline claim can be considered established.

major comments (3)
  1. [Statistical Considerations; Results, Table 3] The unit of analysis for the primary ICC is not specified. The Methods state that the ICC was computed using a two-way fixed single-score model for absolute agreement, but the reader cannot determine whether the 47 test patients × 6 VOIs were pooled into a single ICC. If pooled, the between-VOI variance—systematically different uptake magnitudes in caudate, putamen, and GP—will inflate the ICC for both methods, and the reported superiority of DaT-CTLESS (0.96) over UAC (0.44) may reflect the methods' ability to reproduce the overall VOI pattern rather than accurate per-region quantification. The paper does not report per-VOI ICCs, nor does it report the confidence interval or p-value for the ICC difference, despite the Methods stating that a bootstrapping strategy would be used for this difference. Thus the primary claim of a significantly higher correlation with CTAC is not yet supported by the reported statistical analysis.
  2. [Statistical Considerations] The power analysis is designed to test a single ICC against a null value (0.90 vs 0.75) using Walter et al.'s approach, not to detect a difference between two correlated ICCs obtained from the same set of subjects. It also does not account for the clustered, repeated-measures structure of six VOIs per patient. Consequently, the sample size of N=47 has no demonstrated power to support the primary comparison, and the F-test cited there cannot be directly applied to the DaT-CTLESS versus UAC ICC difference. The authors should either re-frame the power analysis for the actual comparison or justify why the simpler analysis is sufficient.
  3. [Results, Table 3 and Fig. 9] The reported ICC for DaT-CTLESS (0.96) and the claim of 'excellent agreement' with CTAC rest on a single pooled value. To make the primary endpoint interpretable, the authors should report ICCs per VOI (or per VOI-group) and an ICC computed with a model that treats patients as random effects and accounts for repeated VOIs. Fig. 9 reports ICCs across heterogeneity levels, but again without specifying whether the unit is patient–VOI or patient; the same concern applies there. Providing per-VOI ICCs and a cluster-bootstrap confidence interval for the ICC difference would be a straightforward correction.
minor comments (6)
  1. [Page 1 (header)] The first page contains a note that the manuscript has been accepted for publication in Medical Physics on June 15, 2025; this note is inappropriate for a submitted manuscript and should be removed.
  2. [Abstract] In the Abstract, 'DaT-CLTESS' appears to be a typo for 'DaT-CTLESS' in the third sentence of the Background paragraph and at the start of the Results paragraph.
  3. [Methods, DaT-CTLESS method] The text says the segmentation network was trained to estimate 'white/gray matters, skull, scalp, and the head gear' with a weighted cross-entropy loss, but the choice of weights is not described.
  4. [Results, Fig. 7 caption] The caption states 'Normalized RMSE and SSIM between (a) attenuation maps as well as (b) activity maps obtained by the CTAC method and those obtained by DaT-CTLESS and UAC.' It would help to state explicitly that DaT-CTLESS and UAC are compared against CTAC as reference, and to clarify whether the FoMs in (a) and (b) are computed over the same VOIs or over the whole image.
  5. [Statistical Considerations] The power analysis says 'We found that N = 33 samples were needed to detect an ICC under the proposed method of 0.90 against a null ICC of 0.75' but the test dataset includes 47 patients; the text should explain why 47 was chosen over 33 (e.g., to accommodate the 23 group B patients).
  6. [Discussion] The statement that DaT-CTLESS is expected to be insensitive to patient motion because motion equally affects photopeak and scatter-window data is plausible but not directly tested in the trial; it should be phrased as a hypothesis rather than a demonstrated property.

Circularity Check

0 steps flagged · score 1.0 of 10

No significant circularity: the DaT-CTLESS evaluation is a held-out supervised-learning validation with independently assigned attenuation coefficients.

full rationale

The paper's derivation chain is not circular. The network is trained to segment scatter- and photopeak-window reconstructions into attenuation regions using CT-derived segmentation labels from 150 training patients, then each region is assigned a predefined attenuation coefficient from known tissue properties. The loss is weighted cross-entropy against CT-derived segmentations, and the attenuation coefficients are not optimized against the ICC or NRMSE endpoints. Evaluation is performed on 47 held-out virtual patients not used in training, so the reported ICC of 0.96 is an empirical generalization result rather than a fitted prediction. CTAC uses the same CT-derived attenuation maps that generated the simulated projections, making it a well-defined reference, but DaT-CTLESS must recover the attenuation structure from the scatter-window reconstructions without access to the CT; the agreement is therefore not forced by construction. The self-citations, including the Fisher-information analysis of scatter-window data (ref 32), the prior CTLESS work for cardiac SPECT (refs 37-38), and the RELAINCE evaluation framework (ref 39), motivate the approach and trial design but are not used as proof of the reported outcome. The skeptical concern about pooled-VOI ICC is a statistical-inference issue, not a circularity issue; no equation in the paper reduces to its own input, and no fitted parameter is renamed as a prediction.

Assumptions & free parameters 1 free parameters · 4 assumptions · 0 invented entities

No new physical entities, forces, or particles are introduced. DaT-CTLESS is an algorithmic method, not an entity. The free parameter is the set of region-specific attenuation coefficients, which are predefined from literature but not numerically reported in the manuscript.

free parameters (1)
  • regional attenuation coefficients mu_k = not reported
    The method assigns a predefined attenuation coefficient to each segmented region (white/gray matter, skull, scalp, head gear) in Eq. 5. The specific numerical values are not given in the manuscript, so the exact attenuation map is underspecified; different values would change the corrected uptake.
assumptions (4)
  • domain assumption Scatter-energy window projection data contains sufficient information to estimate the attenuation distribution.
    Invoked in the Introduction and Methods (Eq. 2-4); relies on prior work (refs 32,33).
  • domain assumption The attenuation coefficient is constant within each segmented region.
    Used in Eq. 5 to build the estimated attenuation map.
  • domain assumption SIMIND Monte Carlo simulation accurately models the clinical SPECT systems and scatter physics.
    The entire trial is based on simulated projections; the validity of the evaluation depends on this.
  • domain assumption The U-net segmentation network trained on CT-derived labels generalizes to new patients and scanners.
    The method's success rests on the network learning a transferable mapping from scatter and photopeak reconstructions to tissue regions; tested only within the simulation.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Development and in silico imaging trial evaluation of a deep-learning-based transmission-less attenuation compensation method for DaT SPECT." pith.science (2026). https://pith.science/paper/KZ23ARYH

@misc{pith2026250620781,
  author       = {Pith},
  title        = {Pith review of: Development and in silico imaging trial evaluation of a deep-learning-based transmission-less attenuation compensation method for DaT SPECT},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/KZ23ARYH}},
  note         = {Machine review of arXiv:2506.20781}
}
read the original abstract

Quantitative measures of dopamine transporter (DaT) uptake in caudate, putamen, and globus pallidus derived from DaT-single-photon emission computed tomography (SPECT) images are being investigated as biomarkers to diagnose, assess disease status, and track the progression of Parkinsonism. Reliable quantification from DaT-SPECT images requires performing attenuation compensation (AC), typically with a separate X-ray CT scan. Such CT-based AC (CTAC) has multiple challenges, a key one being the non-availability of X-ray CT component on many clinical SPECT systems. Even when a CT is available, the additional CT scan leads to increased radiation dose, costs, and complexity, potential quantification errors due to SPECT-CT misalignment, and higher training and regulatory requirements. To overcome the challenges with the requirement of a CT scan for AC in DaT SPECT, we propose a deep learning (DL)-based transmission-less AC method for DaT-SPECT (DaT-CTLESS). An in silico imaging trial, titled ISIT-DaT, was designed to evaluate the performance of DaT-CTLESS on the regional uptake quantification task. We observed that DaT-CTLESS yielded a significantly higher correlation with CTAC than that between UAC and CTAC on the regional DaT uptake quantification task. Further, DaT-CLTESS had an excellent agreement with CTAC on this task, significantly outperformed UAC in distinguishing patients with normal versus reduced putamen SBR, yielded good generalizability across two scanners, was generally insensitive to intra-regional uptake heterogeneity, demonstrated good repeatability, exhibited robust performance even as the size of the training data was reduced, and generally outperformed the other considered DL methods on the task of quantifying regional uptake across different training dataset sizes. These results provide a strong motivation for further clinical evaluation of DaT-CTLESS.

Figures

Figures reproduced from arXiv: 2506.20781 by the authors.

Figure 11
Figure 11. Normalized RMSE (NRMSE) between the estimated DaT uptake and the ground truth [PITH_FULL_IMAGE:figures/full_fig_p025_11.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

63 extracted references · 62 canonical work pages

  1. [1]

    The Emerging Evidence of the Parkinson Pandemic

    Dorsey ER, Sherer T , Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018;8(s1):S3-S8

    work page 2018

  2. [2]

    Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

    Saeed U, Compagnone J, Aviv RI, et al. Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts. Translational Neurodegeneration. 2017;6(1):8

    work page 2017

  3. [3]

    The impact of DaTscan in the diagnosis of Parkinson disease

    Gayed I, Joseph U, Fanous M, et al. The impact of DaTscan in the diagnosis of Parkinson disease. Clin Nucl Med. 2015;40(5):390-393

    work page 2015

  4. [4]

    The dopamine transporter: immunochemical characterization and localization in brain

    Ciliax B, Heilman C, Demchyshyn L, et al. The dopamine transporter: immunochemical characterization and localization in brain. The Journal of Neuroscience. 1995;15(3):1714- 1723

    work page 1995

  5. [5]

    Importance of bone attenuation in brain SPECT quantification

    Stodilka RZ, Kemp BJ, Prato FS, Nicholson RL. Importance of bone attenuation in brain SPECT quantification. J Nucl Med. 1998;39(1):190-197

    work page 1998

  6. [6]

    Impact of CT attenuation correction by SPECT/CT in brain perfusion images

    Ishii K, Hanaoka K, Okada M, et al. Impact of CT attenuation correction by SPECT/CT in brain perfusion images. Ann Nucl Med. 2012;26(3):241-247

    work page 2012

  7. [7]

    Review and current status of SPECT scatter correction

    Hutton BF, Buvat I, Beekman FJ. Review and current status of SPECT scatter correction. Phys Med Biol. 2011;56(14):R85-R112

    work page 2011

  8. [8]

    Scatter and attenuation correction in technetium- 99m brain SPECT

    Hashimoto J, Kubo A, Ogawa K, et al. Scatter and attenuation correction in technetium- 99m brain SPECT. J Nucl Med. 1997;38(1):157-162. 32

    work page 1997

Show all 63 references
  1. [9]

    Model-based compensation for quantitative 123I brain SPECT imaging

    Du Y , Tsui BM, Frey EC. Model-based compensation for quantitative 123I brain SPECT imaging. Phys Med Biol. 2006;51(5):1269

    2006

  2. [10]

    (2021) Global SPECT market 2017-2021

    Technavio. (2021) Global SPECT market 2017-2021. https://www.technavio.com/report/global-medicalimaging-global-spect-market-2017- 2021

    2021

  3. [11]

    High-sensitivity brain SPECT system using cadmium telluride (CdTe) semiconductor detector and 4-pixel matched collimator

    Suzuki A, Takeuchi W, Ishitsu T , et al. High-sensitivity brain SPECT system using cadmium telluride (CdTe) semiconductor detector and 4-pixel matched collimator. Phys Med Biol. 2013;58(21):7715

    2013

  4. [12]

    Basic performance and stability of a CdTe solid-state detector panel

    Tsuchiya K, Takahashi I, Kawaguchi T , et al. Basic performance and stability of a CdTe solid-state detector panel. Ann Nucl Med. 2010;24(4):301-311

    2010

  5. [13]

    Effect of misregistration between SPECT and CT images on attenuation correction for quantitative bone SPECT imaging

    Sakoshi M, Matsutomo N, Yamamoto T , Sato E. Effect of misregistration between SPECT and CT images on attenuation correction for quantitative bone SPECT imaging. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(5):452-458

    2018

  6. [14]

    The influence of misregistration between CT and SPECT images on the accuracy of CT-based attenuation correction of cardiac SPECT/CT imaging: Phantom and clinical studies

    Saleki L, Ghafarian P , Bitarafan-Rajabi A, Yaghoobi N, Fallahi B, Ay MR. The influence of misregistration between CT and SPECT images on the accuracy of CT-based attenuation correction of cardiac SPECT/CT imaging: Phantom and clinical studies. Iran J Nucl Med. 2019;27(2):63-72

    2019

  7. [15]

    Impact of Misregistration between the Myocardial Perfusion Images and CT Attenuation Correction Map on the% up Take with 17 Segments Polar Map

    Yoshikawa K, Chono T , Asanuma O, Yama N. Impact of Misregistration between the Myocardial Perfusion Images and CT Attenuation Correction Map on the% up Take with 17 Segments Polar Map. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(9):892-899

    2019

  8. [16]

    The pinwheel sign: artifact from head rotation during SPECT acquisition for dopamine transporter imaging

    Janicek AK, Avery RJ, Kuo PH. The pinwheel sign: artifact from head rotation during SPECT acquisition for dopamine transporter imaging. J Nucl Med Technol. 2014;42(1):75- 76

    2014

  9. [17]

    The semicolon sign: dopamine transporter imaging artifact from head tilt

    Covington MF, McMillan NA, Avery RJ, Kuo PH. The semicolon sign: dopamine transporter imaging artifact from head tilt. J Nucl Med Technol. 2013;41(2):105-107

    2013

  10. [18]

    A new approach to the emission computerized tomography problem: simultaneous calculation of attenuation and activity coefficients

    Censor Y , Gustafson DE, Lent A, Tuy H. A new approach to the emission computerized tomography problem: simultaneous calculation of attenuation and activity coefficients. IEEE Trans Nucl Sci. 1979;26(2):2775-2779

    1979

  11. [19]

    An EM algorithm for estimating SPECT emission and transmission parameters from emissions data only [published online ahead of print 2001/05/09]

    Krol A, Bowsher JE, Manglos SH, Feiglin DH, Tornai MP , Thomas FD. An EM algorithm for estimating SPECT emission and transmission parameters from emissions data only [published online ahead of print 2001/05/09]. IEEE Trans Med Imaging. 2001;20(3):218- 232

    2001

  12. [20]

    A transmission‐map‐based scatter correction technique for SPECT in inhomogeneous media

    Welch A, Gullberg GT , Christian PE, Datz FL, Morgan HT. A transmission‐map‐based scatter correction technique for SPECT in inhomogeneous media. Med Phys. 1995;22(10):1627-1635

    1995

  13. [21]

    Segmentation of the body and lungs from Compton scatter and photopeak window data in SPECT: a Monte-Carlo investigation [published online ahead of print 1996/01/01]

    Pan TS, King MA, de Vries DJ, Ljungberg M. Segmentation of the body and lungs from Compton scatter and photopeak window data in SPECT: a Monte-Carlo investigation [published online ahead of print 1996/01/01]. IEEE Trans Med Imaging. 1996;15(1):13- 24

    1996

  14. [22]

    Use of measured scatter data for the attenuation correction of single photon emission tomography without transmission scanning

    Cade SC, Arridge S, Evans MJ, Hutton BF. Use of measured scatter data for the attenuation correction of single photon emission tomography without transmission scanning. Med Phys. 2013;40(8):082506. 33

    2013

  15. [23]

    Joint reconstruction of activity and attenuation map using LM SPECT emission data

    Jha AK, Clarkson E, Kupinski MA, Barrett HH. Joint reconstruction of activity and attenuation map using LM SPECT emission data. Paper presented at: Proceedings of SPIE--the International Society for Optical Engineering2013

  16. [24]

    Deep learning-based attenuation map generation for myocardial perfusion SPECT

    Shi L, Onofrey JA, Liu H, Liu Y-H, Liu C. Deep learning-based attenuation map generation for myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging. 2020;47(10):2383-2395

    2020

  17. [25]

    Direct and indirect strategies of deep-learning-based attenuation correction for general purpose and dedicated cardiac SPECT

    Chen X, Zhou B, Xie H, et al. Direct and indirect strategies of deep-learning-based attenuation correction for general purpose and dedicated cardiac SPECT. Eur J Nucl Med Mol Imaging. 2022;49(9):3046-3060

    2022

  18. [26]

    CT-free attenuation correction for dedicated cardiac SPECT using a 3D dual squeeze-and-excitation residual dense network

    Chen X, Zhou B, Shi L, et al. CT-free attenuation correction for dedicated cardiac SPECT using a 3D dual squeeze-and-excitation residual dense network. J Nucl Cardiol. 2022;29(5):2235-2250

    2022

  19. [27]

    Deep Learning-based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT

    Shanbhag AD, Miller RJH, Pieszko K, et al. Deep Learning-based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT. J Nucl Med. 2022. doi: 10.2967/jnumed.122.264429:jnumed.122.264429

    2022 doi

  20. [28]

    “Virtual” attenuation correction: improving stress myocardial perfusion SPECT imaging using deep learning

    Hagio T , Poitrasson-Rivière A, Moody JB, et al. “Virtual” attenuation correction: improving stress myocardial perfusion SPECT imaging using deep learning. Eur J Nucl Med Mol Imaging. 2022;49(9):3140-3149

    2022

  21. [29]

    Attenuation correction using deep learning for brain perfusion SPECT images

    Sakaguchi K, Kaida H, Yoshida S, Ishii K. Attenuation correction using deep learning for brain perfusion SPECT images. Ann Nucl Med. 2021;35:589-599

    2021

  22. [30]

    Development of attenuation correction methods using deep learning in brain‐perfusion single‐photon emission computed tomography

    Murata T , Yokota H, Yamato R, et al. Development of attenuation correction methods using deep learning in brain‐perfusion single‐photon emission computed tomography. Med Phys. 2021;48(8):4177-4190

    2021

  23. [31]

    Automatic attenuation map estimation from SPECT data only for brain perfusion scans using convolutional neural networks

    Chen Y , Goorden MC, Beekman FJ. Automatic attenuation map estimation from SPECT data only for brain perfusion scans using convolutional neural networks. Phys Med Biol. 2021;66(6):065006

    2021

  24. [32]

    Fisher information analysis of list-mode SPECT emission data for joint estimation of activity and attenuation distribution

    Rahman MA, Zhu Y , Clarkson E, Kupinski MA, Frey EC, Jha AK. Fisher information analysis of list-mode SPECT emission data for joint estimation of activity and attenuation distribution. Inverse problems. 2020;36(8):084002

    2020

  25. [33]

    Determination of the attenuation map in emission tomography

    Zaidi H, Hasegawa B. Determination of the attenuation map in emission tomography. J Nucl Med. 2003;44(2):291-315

    2003

  26. [34]

    A tissue-fraction estimation-based segmentation method for quantitative dopamine transporter SPECT

    Liu Z, Moon HS, Li Z, et al. A tissue-fraction estimation-based segmentation method for quantitative dopamine transporter SPECT. Med Phys. 2022;49(8):5121-5137

    2022

  27. [35]

    Deep-learning-based cross-modality striatum segmentation for dopamine transporter SPECT in Parkinson’s disease

    Wang H, Jiang H, Chen G, et al. Deep-learning-based cross-modality striatum segmentation for dopamine transporter SPECT in Parkinson’s disease. IEEE Trans Radiat Plasma Med Sci. 2024

    2024

  28. [36]

    AI in SPECT Imaging: Opportunities and Challenges

    Yang F, Lei B, Zhou Z, Song T-A, Balaji V, Dutta J. AI in SPECT Imaging: Opportunities and Challenges. Paper presented at: Seminars in Nuclear Medicine2025

  29. [37]

    Development and task-based evaluation of a scatter- window projection and deep learning-based transmission-less attenuation compensation method for myocardial perfusion SPECT

    Yu Z, Rahman MA, Siegel B, Jha AK. Development and task-based evaluation of a scatter- window projection and deep learning-based transmission-less attenuation compensation method for myocardial perfusion SPECT. Paper presented at: Proc. SPIE Med. Imag2023

  30. [38]

    CTLESS: A scatter-window projection and deep learning-based transmission-less attenuation compensation method for myocardial perfusion SPECT

    Yu Z, Rahman MA, Abbey CK, et al. CTLESS: A scatter-window projection and deep learning-based transmission-less attenuation compensation method for myocardial perfusion SPECT. IEEE Trans Med Imaging. 2024;44(3):1308-1320. 34

    2024

  31. [39]

    Nuclear medicine and artificial intelligence: best practices for evaluation (the RELAINCE guidelines)

    Jha AK, Bradshaw TJ, Buvat I, et al. Nuclear medicine and artificial intelligence: best practices for evaluation (the RELAINCE guidelines). J Nucl Med. 2022;63(9):1288-1299

    2022

  32. [40]

    Virtual clinical trials in medical imaging: a review

    Abadi E, Segars WP , Tsui BM, et al. Virtual clinical trials in medical imaging: a review. J Med Imaging. 2020;7(4):042805-042805

    2020

  33. [41]

    Evaluation of digital breast tomosynthesis as replacement of full-field digital mammography using an in silico imaging trial

    Badano A, Graff CG, Badal A, et al. Evaluation of digital breast tomosynthesis as replacement of full-field digital mammography using an in silico imaging trial. JAMA Network Open. 2018;1(7):e185474-e185474

    2018

  34. [42]

    Objective task-based evaluation of artificial intelligence-based medical imaging methods: framework, strategies, and role of the physician

    Jha AK, Myers KJ, Obuchowski NA, et al. Objective task-based evaluation of artificial intelligence-based medical imaging methods: framework, strategies, and role of the physician. Pet Clin. 2021;16(4):493-511

    2021

  35. [43]

    SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0

    Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53(1):154-163

    2012

  36. [44]

    EANM procedure guidelines for brain neurotransmission SPECT using 123 I-labelled dopamine transporter ligands, version 2

    Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123 I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443-450

    2010

  37. [45]

    Attention gated networks: Learning to leverage salient regions in medical images

    Schlemper J, Oktay O, Schaap M, et al. Attention gated networks: Learning to leverage salient regions in medical images. Med Image Anal. 2019;53:197-207

    2019

  38. [46]

    Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images

    Jenkinson M, Bannister P , Brady M, Smith S. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images. Neuroimage. 2002;17(2):825-841

    2002

  39. [47]

    FreeSurfer

    Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774-781

    2012

  40. [48]

    Imaging analysis of Parkinson’s disease patients using SPECT and tractography

    Son S-J, Kim M, Park H. Imaging analysis of Parkinson’s disease patients using SPECT and tractography. Sci Rep. 2016;6(1):38070

    2016

  41. [49]

    Joint regional uptake quantification of thorium-227 and radium-223 using a multiple-energy-window projection-domain quantitative SPECT method

    Li Z, Benabdallah N, Laforest R, Wahl RL, Thorek DL, Jha AK. Joint regional uptake quantification of thorium-227 and radium-223 using a multiple-energy-window projection-domain quantitative SPECT method. IEEE Trans Med Imaging. 2024

    2024

  42. [50]

    Investigation of the relationship between linear attenuation coefficients and CT Hounsfield units using radionuclides for SPECT

    Brown S, Bailey DL, Willowson K, Baldock C. Investigation of the relationship between linear attenuation coefficients and CT Hounsfield units using radionuclides for SPECT. Appl Radiat Isot. 2008;66(9):1206-1212

    2008

  43. [51]

    A clustering algorithm for liver lesion segmentation of diffusion-weighted MR images

    Jha AK, Rodríguez JJ, Stephen RM, Stopeck AT. A clustering algorithm for liver lesion segmentation of diffusion-weighted MR images. Paper presented at: 2010 IEEE Southwest Symposium on Image Analysis & Interpretation (SSIAI)2010

    2010

  44. [52]

    One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I] FPCIT SPECT

    Booij J, Hemelaar JT , Speelman JD, de Bruin K, Janssen AG, van Royen EA. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I] FPCIT SPECT. J Nucl Med. 1999;40(5):753-761

    1999

  45. [53]

    SIMIND Monte Carlo simulation of a single photon emission CT

    Bahreyni Toossi MT , Islamian JP , Momennezhad M, Ljungberg M, Naseri SH. SIMIND Monte Carlo simulation of a single photon emission CT. J Med Phys. 2010;35(1):42-47

    2010

  46. [54]

    The impact of reconstruction method on the quantification of DaTSCAN images

    Dickson JC, Tossici-Bolt L, Sera T , et al. The impact of reconstruction method on the quantification of DaTSCAN images. Eur J Nucl Med Mol Imaging. 2010;37:23-35

    2010

  47. [55]

    A guideline of selecting and reporting intraclass correlation coefficients for reliability research

    Koo TK, Li MY . A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-163

    2016

  48. [56]

    Sample size and optimal designs for reliability studies

    Walter S, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med. 1998;17(1):101-110. 35

    1998

  49. [57]

    Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988.837-845

    1988

  50. [58]

    Attenuation compensation in 99mTc SPECT brain imaging: a comparison of the use of attenuation maps derived from transmission versus emission data in normal scans

    Licho R, Glick SJ, Xia W, Pan T-S, Penney BC, King MA. Attenuation compensation in 99mTc SPECT brain imaging: a comparison of the use of attenuation maps derived from transmission versus emission data in normal scans. J Nucl Med. 1999;40(3):456-463

    1999

  51. [59]

    Influence of photon scattering and attenuation on ROI analysis in brain perfusion single-photon emission tomographic imaging of normal subjects

    Bai J, Hashimoto J, Ogawa K, et al. Influence of photon scattering and attenuation on ROI analysis in brain perfusion single-photon emission tomographic imaging of normal subjects. Ann Nucl Med. 2005;19:567-572

    2005

  52. [60]

    Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach

    Brenner DJ, Sachs RK. Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach. Radiat Environ Biophys. 2006;44:253- 256

    2006

  53. [61]

    International commission on radiological protection

    Cousins C, Miller D, Bernardi G, et al. International commission on radiological protection. ICRP publication. 2011;120:1-125

    2011

  54. [62]

    Statistical evaluation of test- retest studies in PET brain imaging

    Baumgartner R, Joshi A, Feng D, Zanderigo F, Ogden RT. Statistical evaluation of test- retest studies in PET brain imaging. EJNMMI research. 2018;8:1-9

    2018

  55. [63]

    Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease

    Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med. 1988;318(14):876-880

    1988

Pith tools

Reviewed August 6, 2026 · model on record in the stance chip above.